Dubai prostate checks: PSA starts near AED 150, MRI packages reach AED 2,300

For a man in Dubai asking what early prostate cancer detection actually involves, the first number is usually a PSA blood test priced at about AED 150 to AED 300, followed by urology review if the result is raised.

The business impact is straightforward. Screening converts a vague men's health concern into a pathway with prices, turnaround times, imaging capacity and insurance questions. Dubai Health Authority (DHA) regulates Dubai providers, Department of Health Abu Dhabi (DOH Abu Dhabi) regulates Abu Dhabi and Al Ain, and Ministry of Health and Prevention (MOHAP) regulates federal health services and the northern emirates.

What the first test measures

PSA means prostate-specific antigen. It is a blood marker. A raised result can point to prostate cancer, benign enlargement, inflammation or recent prostate manipulation. Cleveland Clinic Abu Dhabi lists age-adjusted PSA reference ranges of 0-2.5 ng/ml for ages 40-50, 2.5-3.5 ng/ml for ages 50-60, 3.5-4.5 ng/ml for ages 60-70, and 4.5-5.5 ng/ml for ages 70-80.

Those numbers do not diagnose cancer on their own. They tell the GP, urologist or family medicine doctor whether a repeat PSA, rectal examination, urine test, MRI or biopsy discussion is needed. For operators, PSA screening creates downstream demand in urology, radiology and pathology, rather than oncology alone.

• Age 50 is the common starting point cited by several UAE hospital pages for average-risk men.
• Age 45 is commonly used when there is family history or higher risk.
• Age 40 appears in DOH Abu Dhabi Circular No. 2025/68, which says providers should consider prostate cancer screening from that age.
• Age 55-69 is the group where the US National Cancer Institute says PSA screening should be an individual decision after discussion with a clinician.

What a Dubai patient should budget

Published Dubai prices show a low entry cost, then a steep increase when imaging is added. Doctors Clinic Diagnostic Center lists PSA testing from AED 150. iCARE Clinics lists a PSA test with consultation at AED 199. Mediclinic Middle East lists a prostate package at AED 225, including consultation, PSA test, urine analysis and follow-up. Emirates Hospitals Group has advertised AED 250 in November and AED 300 normally for PSA with consultation.

Imaging changes the economics. CMC Dubai lists an MRI and PSA prostate cancer screening package at AED 2,300. That page cites men aged 50-75 and asymptomatic men as criteria. A facility offering men's health checks should price the first visit separately from MRI-led pathways, because the journey can move from a sub-AED 300 lab test to a four-figure imaging bill.

Insurance is the harder number. Daman and Thiqa are central to Abu Dhabi coverage. Sukoon is active in Dubai health insurance. Coverage can depend on whether the claim is coded as preventive screening, diagnostic testing after symptoms, or follow-up after an abnormal result. Patients should ask for the policy schedule and pre-approval rule before MRI or biopsy. HR teams should ask brokers to state the PSA, urology and prostate MRI benefit in writing for men aged 40 and above.

What happens after a raised PSA

The usual sequence is repeat testing or clinical review first, then imaging or biopsy if the urologist sees enough risk. The US National Cancer Institute says PSA levels can rise because of infection, inflammation, benign enlargement or cancer, and says men aged 70 and above are generally outside routine PSA screening recommendations. UAE clinicians may adjust that decision for life expectancy, symptoms and family history.

For Dubai providers, the operational checkpoint is referral discipline. A corporate screening camp can produce anxious patients with mild PSA rises. A good pathway gives the patient a result, a written explanation, and a urology appointment route within days. It should also state which provider is licensed for the next step under DHA rules. In Abu Dhabi and Al Ain, the same check should reference DOH Abu Dhabi licensing. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the relevant regulator is MOHAP unless a local health authority applies.

The latest treatment discussion matters only after diagnosis. Early detection is the gatekeeping system before surgery, radiation, hormone therapy or surveillance enters the conversation. For buyers and operators, the measurable items are PSA price, result time, urology access, MRI availability, pre-approval rules and documented follow-up.

Patients and referring doctors should use the UAE Open Healthcare Directory to find licensed oncology providers, then confirm DHA, DOH Abu Dhabi or MOHAP licensing, insurance acceptance and prostate cancer services before booking.